Mauricio Cortes
Senior Director & Head of Discovery Science Cellarity
Mauricio Cortes serves as Senior Director and Head of Discovery Science at Cellarity. Prior to this, he worked at CRISPR Therapeutics, working on the development of CTX001, the first CRISPR-Cas9 gene based clinical trial to treat Beta-thalassemia and sickle cell disease. He conducted research at Harvard Medical School on the impact of vitamin D3 availability on hematopoietic stem cell homeostasis, and holds a PhD from the University of Chicago.
Seminars
Whilst proteomics has the potential to reveal the workings of the proteome and demystify disease signalling pathways, part of the story is still missing. Combining genomics, transcriptomics, and metabolomics insights to contextualize proteomics is vital to better understand pathology and guide therapeutic discovery.
This workshop will gather experts to discuss how to:
- Effectively harmonize and integrate genomics, transcriptomics, and metabolomics data to bolster understanding of proteomics and generate a more holistic view of pathology and therapeutic response
- Employ innovative computational and AI tools to streamline multi-omics workflows and maximize time and cost-efficiency of large-scale data analysis
- Apply multi-omics across drug discovery, from deconvoluting disease pathways and identifying novel targets to validating biomarkers and optimizing hit identification
